TOPG:TASETop Group Software Ltd. Analysis

Top Glove is trading at MYR 0.68, barely above the computed support level of MYR 0.66 and well below its DCF‑derived fair value of MYR 1.21, implying a modest upside of roughly 6 %. The 14‑day RSI of 35 signals oversold conditions, yet the MACD remains bearish and volume is on a decreasing trend, suggesting limited short‑term momentum. The stock’s PE of 34 is notably higher than the industry average of 26, while the forward PE of 23.9 points to a potential earnings improvement but still reflects a premium valuation. Revenue growth of 31.9 % and a dividend yield of 0.71 % provide some growth and income appeal, though margins are thin (gross margin 17 %) and ROE is only 3.8 %. Recent analyst commentary notes that earnings may have peaked as Middle‑East tensions ease, tempering near‑term profit expectations, while insider buying over the past year adds a bullish nuance. High 30‑day volatility (≈40 %) and a beta near zero indicate a stock that is less correlated with broader market moves but prone to sharp price swings. Overall, the company sits in a medium‑risk segment of the healthcare‑medical supplies sector, with moderate regulatory and geographic exposures.